Evasion of Type I Interferon by SARS-CoV-2.
Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. · 2020
Read Evasion of Type I Interferon by SARS-CoV-2. by Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7501843.txt.
Description
Xia and co-authors map how SARS-CoV-2 evades type I interferon, the cell's early antiviral alarm. Viral growth and host response together shape COVID-19. Work on the virus's evasion tools was lacking.
An unbiased screen found three proteins that block interferon production, each by a distinct trick. Nsp6 binds the kinase TBK1 and mutes a key activation step. Nsp13 binds TBK1 and blocks its own activation mark. ORF6 binds an import protein and stops IRF3 from entering the nucleus. Two more protein sets block interferon signaling at STAT1 and STAT2. Nsp1 and nsp6 from this virus beat their SARS and MERS kin at suppression. Test replicons with those swaps grew better under interferon.
Catalog record
| CREATOR | Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |